Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000237

EVP and CMO sold 1,020 shares at $462.17 ($471,413)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bozic Carmen · EVP and CMO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-18 Sale : show line 1 in the form 10b5-1 −1,020 $462.17 $471,413 15,933 D
Open-market sales · 1,020 sh · avg $462.17 · $471,413
Loading xslF345X06/wk-form4_1782245334.xml…